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Abstract
Studies of enteric diseases have historically focused on observations of clinical diarrhea as a cause of mortality and
morbidity. Emerging evidence suggests that diarrhea dramatically underestimates both exposure to
enteropathogens and the long-term consequences arising from infection. High burden of pathogens in the gut,
even in the absence of diarrhea, is common in infants in low and middle income countries. Continual challenge by
pathogens, in conjunction with an inadequate diet stimulates an inflammatory disease that alters the structure of
the gut, metabolic and immunological pathways and changes the microbiome. Both diarrhea and enteropathogen
infection have been associated with reduced growth, reduced cognitive development, and reduced vaccine
efficacy suggesting that the burden of diarrheal disease is dramatically underestimated.
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Background
The importance of diarrheal disease
The importance of diarrhoeal disease to child develop-
ment in low and middle income countries (LMIC) was
highlighted by seminal work in the 1950s and ‘60s [1, 2].
Subsequent research over the next two decades focused
on quantifying health outcomes by the frequency and
severity of symptoms [3]. Interventions to interrupt
transmission routes [4–6] have simultaneously greatly
reduced mortality [7] and rates of diarrheal incidence
[8]. Nevertheless, continuing interest in diarrhea reflects
its role as the second most common cause of death in
children under 5 years old [9].
The burden of diarrhea, however, is not solely
estimated by mortality. It is a proximate driver of
malnutrition [10], and related to many insidious morbid-
ities [3, 11]. A considerable body of evidence has rear-
ranged the linear United Nations Children's Emergency
Fund (UNICEF) framework [10] of malnutrition into a
cyclical conceptual model that describes a ‘vicious cycle
of poverty’ [11] (Fig. 1): (a) infection with enteric patho-
gens is associated with b) impaired gut-function [12–15]
that can (c) exacerbate effects of malnutrition [16], for
example, restricting appropriate processing of nutrients
[17, 18] necessary for (d) physical [17–20] and (e) cognitive
development [21–23] as well as (f) altering immune re-
sponses [16, 24], thereby impairing a child’s ability to resist
a) recurrent infections [17, 25] and illness [26]. Scaling to a
population from an individual, malnutrition as a disease as-
sociated with poverty increases (g) behaviors and environ-
ments that propagate the syndrome. It is worth noting that
the language of the vicious cycle has evolved from a focus
on diarrhea [27] to specifically implicating enteropathogen
infection absent diarrhea [11, 28]. Advances in diagnostics
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are likely to provide further evidence for the role of cryptic
infections in the absence of overt symptoms.
Main text
Diarrhea and enteropathogens
Recorded rates of diarrhea are unlikely to reflect the true
prevalence of disease and thereby dramatically under-
estimate the untoward consequences of enteropathogen
infections. In England where care is readily available, un-
reported diarrhea was 5.8 times higher than those that
were recorded [29] and in Canada only 10 % of adults
sought care [30]. Where symptoms are considered com-
mon or expected, they are less likely to be reported.
Early research focused on diarrheal symptoms on the
presumption that childhood diarrhea in LMIC settings
was the product of underlying infection [31]. Identifica-
tion of which pathogen was causing diarrhea was just
awaiting development of methods of detection. In the
1960s recovering a pathogen from diarrheal stool was
seldom possible in more than 40 % of cases. For recent
studies the challenge has been to ascribe causation be-
tween the many pathogens detected, either in the same
stool or given the high rates of detection in the absence
of diarrhea. In the MAL-ED study 76.9 % diarrheal
stools and 64.9 % of non-diarrheal stools had at least
one pathogen detected and 41.0 % and 29.0 %, respect-
ively, had at least two [32]. Similarly in the Global
Enteric Multicenter Study (GEMS), though examining
moderate to severe diarrhea rather than the prospective
community cohort of MAL-ED, found a comparable
83 % of cases and 72 % of controls had at least one
pathogen, with two or more identified in 45 % cases and
31 % controls [33]. Rates of detection regardless of coin-
cident symptoms are only likely to rise as more sophisti-
cated technology (e.g. qPCR) enables both increased
rates of detection as well as quantitation of pathogen
burden [34, 35].
The attribution of diarrhea to specific pathogens is
more challenging when they are coincident, although es-
timates appear remarkably similar to those of the 1960s
when a single pathogen was detected in stool. In GEMS,
an average of 44 % cases of moderate-to-severe diarrhea
in infants and 47 % of cases in toddlers were attributed
to pathogens. MAL-ED attributed 19.1 % and 33.1 % of
diarrheal episodes in the first and second year of life re-
spectively to enteropathogens. Even if pathogens appear
less causally linked to diarrhea than previously expected,
the high prevalence of these organisms in the absence of
diarrhea raises the question of whether or not these or-
ganisms are causing more covert damage?
Enteropathogens and enteric disease
Histopathogical studies, dating back to the 1960s, of in-
testinal biopsy samples revealed physiological and func-
tional changes in the gut - villus atrophy and crypt
hyperplasia [36–38] that have been attributed to living
in an environment where repeated enteropathogen infec-
tions were common [39]. In an effort to find non-
invasive diagnostics and the absence of overt pathogno-
monic symptoms, a growing collection of biomarkers
Fig. 1 The conceptual model of the “vicious cycle of poverty”, linking enteric infections to gut dysfunction, impaired nutrient absorption,
malnutrition and restricted physical and cognitive development. Stages within this cycle are described in the text
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[40, 41] are emerging that can detect reduced absorptive
capacity [39, 42], increased permeability [43] and
chronic intestinal inflammation [44, 45] that have be-
come indicative of an inflammatory condition induced
by enteropathogens called environmental enteropathy
(EE) [46, 47].
Many studies have examined biomarkers of EE and
found associations between EE and malnutrition. The ra-
tio of lactulose to mannitol, as an indicator of absorptive
capacity and/or breaches of the mucosal barrier has ex-
plained as much as 42.9 % of linear and 38.9 % of weight
variability [43] though not consistently in other popula-
tions [48–50]. This variability may be attributed to dif-
ferences in testing procedure, test sensitivity [51, 52], or
to variability in how populations process the two sugars
to drive the ratio [39] and their individual analysis
(sometimes categorized rather than continuous). An-
other individual biomarker of inflammation, REG1B, ex-
plained around 1.5 % of linear growth variation [53].
However, using a broader spectrum of EE biomarkers to
capture multiple aspects of the syndrome achieved a de-
scription of 46.3 % of linear growth variation [24].
Exciting new understanding is emerging from mouse
models that offer not just confirmation of EE, but also
causal explanation. Mice fed a malnourished diet to
mimic diets of children in Bangladesh exhibited 30 % re-
duction in weight gain, however it was only when mal-
nourished mice were additionally exposed to gut
bacteria that they developed similar gut lesions found by
histopathology [16]. The addition of a Bacteroidales and
E. coli cocktail exacerbated much of the intestinal dam-
age of moderate malnutrition including altering bacterial
colonisation, inflammation and immunity to other enter-
opathogens. However, enteropathogens importantly
interact with the commensal microbiome [54, 55], which
is shaped by diet [56–58]. In malnourished children the
gut microbiota remains immature and its composition
and colonisation patterns fail to mature with age as the
microbiota does in well-nourished children. Diet-
induced changes to the gut environment along with fre-
quent exposure to new microbes result in demonstrable
changes in immune and metabolic pathways [16, 59, 60].
Relating the pathways found within mouse models to
observational studies in humans using biomarkers is
proving more difficult, but EE does provide a mechanis-
tic link between enteropathogen exposure and undernu-
trition to growth and development.
Infection and growth
Because it is easily identified, most studies have relied on
diarrheal symptoms as an indication of enteropathogen in-
fection. Diarrhea has long been associated with growth
shortfall; 5, 11 and 20 % of reduced linear growth in
Mexico, Guatemala and Bangladesh respectively [61–63].
A pooled analysis of nine studies found consistent associa-
tions between diarrhea and stunting with 25 % of stunting
prevalence at 2 years old attributed to children with
≥5 diarrhoeal episodes, or alternatively 18 % of stunt-
ing attributed to children who had diarrhoea on ≥2 %
of days from birth to 24 months [64]. Improving sani-
tation and hygiene has been predicted to reduce
stunting by 6 % [65] and even reduce all-cause mor-
tality by 4 % [66].
Quantifying the contribution of individual pathogens
to growth shortfalls has been less frequently examined.
E. coli and Shigella were associated with decreased
weight and length respectively in Bangladesh [63] and in
addition to these pathogens, infection with Campylobac-
ter was associated with reduced linear growth in Peru
[20]. Pathogens, for example Cryptosporidium and Cam-
pylobacter, in diarrhea are associated with greater growth
deficits than those with no symptoms [67, 68] though
the prevalence of the latter is likely to be more common.
Whilst pathogens and diarrhea have been associated
with reduced growth, the effects can be reversible. For
example, weight loss following infection with Shigella
could be reversed with improved diet [69]. In some cases
growth retardation caused by transient infection can
recover without intervention [19]. Repeated infections
diminish the ability to achieve catch-up growth to com-
pensate for growth shortfall [70, 71].
Infection and oral polio vaccine
Malnutrition, has been implicated as a reason for the
disappointing efficacy of oral vaccines in developing
countries [72–74]. Diarrhea at the time of oral polio vac-
cine (OPV) reduces the odds of seroconversion to 0.68
[75], and malnutrition reduced OPV titers by half [76].
Similarly, rotavirus vaccine efficacy, important because
of the association between rotavirus and diarrhea [32,
33], is only 51 % in developing regions [77] and illness
(both diarrheal and respiratory) both during or after
measles vaccination can result in reduced titers [78].
Individual pathogens, in addition to contributing to
overt illness and general malnutrition, can impair vac-
cine efficacy. Plasma phagocytic activity, for example
is reduced by enterotoxigenic E. coli, which addition-
ally reduced complement C3 levels by 50 % [79]. As-
caris infections and small bowel bacterial overgrowth
(SBBO) reduced CVD 103-HgR cholera vaccine re-
sponse [80, 81]. SBBO is associated with gut inflam-
mation [82], an important component of EE which
can result in modulation of immune pathways [16,
24] that can, along with gut microbiota [54, 83], re-
duce the efficacy of vaccines. Mechanisms can include
production of small molecules that are cross-reactive
with oral vaccines and increased mucosal lymphoctyes
and plasmacytes, and notably T-cells [16, 44]. Levine
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[74] suggests two explanations, one in which EE
elicits a chronically pro-inflammatory state that pro-
tects against repeated infection, while at the same
time diminishing response to orally delivered live vac-
cines. Alternatively, a second possibility is that active
immune responses are dampened as the gut micro-
biota and host immunity is modified so that patho-
gens are tolerated rather than cleared [84, 85].
Infection and cognitive development
As diarrheal disease disrupts nutrient processing and
metabolic pathways, one postulated consequence of
the vicious cycle is that repeated infections impair
cognitive development. Correlative evidence gives
some support to this idea, with numerous studies
demonstrating that stunted children perform less
well in early assessment of cognitive performance
and that early tests of cognitive development are
predictive of school readiness and achievement [86].
More specifically, studies have observed that higher
rates of diarrhea [23, 87] and some pathogens [21,
88–90] delay school-readiness though results are
disputable when other correlated factors are
accounted for, such as underlying poverty or malnu-
trition [89, 91].
The consequence of impaired cognitive develop-
ment, most of which has associated with poverty is
estimated to reduce adult income by 5.9 %, and, when
combined with stunting, reduces income by 30.1 %
[86]. This is largely the result of lost years of primary
schooling, through delayed school readiness, high
drop-out rates or reduced learning whilst at school
[92], each of which is estimated to account for a drop
of 6.8 to 10.6 % in adult wages [93]. With reduced
wages, the vicious cycle is perpetuated, with negative
effects on future generations and populations.
Fig. 2 a) The percentage of DALYs in children under 5 years old due to diarrheal disease based on the 2013 Global Burden of Diarrhea estimates
[95]; b) the percentage of children stunted based on data collated by UNICEF, WHO, World Bank showing the most recent national data available
for each country (ranging from 2006 to 2015) [96]
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Conclusions
A mounting body of evidence suggests that the burden
of diarrhea is much greater than the high reported num-
ber of childhood deaths each year. The insidious mor-
bidity ascribed to diarrheal disease is more appropriately
attributed to enteric infection.
Guerrant et al. [94] offered a first attempt to revise es-
timates of diarrheal disease Disability Adjusted Life
Years (DALYs) (Fig. 2). Rather than base 95 % of the
burden on mortality, they accounted for long-term con-
sequences and suggested a conservative doubling of the
disease burden. As further data become available that
can better identify and quantify long-term health effects
of asymptomatic enteric infection, this estimate is likely
to be refined, and will almost certainly be increased, for
example, accounting for at least some of burden of
stunting, which is substantially greater than reflected by
current DALY estimates due to diarrhea per se (Fig. 2).
By explicitly recognising the importance of exposure
to pathogens, singly or in combination, and not being
guided solely by the symptom of diarrhea, targeted
efforts to reduce the compounded damage due to inad-
equate diet and infection may yield greater success than
reducing either separately. It suggests that increased em-
phasis should be placed on improving access to clean
water, adequate sanitation and hygiene (WASH) meth-
odologies that attempt to break transmission routes that
are common to many pathogens along side targeted vac-
cination against high priority pathogens.
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